跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ESPEROCT turoctocog alfa pegol 500 IU powder for injection vial with solvent - TGA Drug Approval Details
Approvals
/
TGA
/
ESPEROCT turoctocog alfa pegol 500 IU powder for injection vial with solvent
Approved
STANDARD
ESPEROCT turoctocog alfa pegol 500 IU powder for injection vial with solvent
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4fcc7ebc4f40698d
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
4fcc7ebc4f40698d
Product Name
ESPEROCT turoctocog alfa pegol 500 IU powder for injection vial with solvent
Artg Id
389599
Artg Name
ESPEROCT turoctocog alfa pegol 500 IU powder for injection vial with solvent
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2023-06-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4fcc7ebc4f40698d
Type
Standard
Back to TGA Approvals